Bard Hit With Warning Letter Over Unapproved Devices, Quality Issues

The GMP Letter
A A
The FDA has come down on C.R. Bard for not addressing quality systems and medical device reporting observations at two of its plants.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00